Zobrazeno 1 - 10
of 862
pro vyhledávání: '"ASCT"'
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 8, Pp 8197-8208 (2024)
Multiple myeloma (MM) first-line treatment algorithms include immuno-chemotherapy (ICT) induction, high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) consolidation, followed by lenalidomide maintenance. After these initial thera
Externí odkaz:
https://doaj.org/article/5fa5f48e35e143108164d9f97ffef067
Autor:
Michele Clerico, Simone Ferrero, Beatrice Alessandria, Gian Maria Zaccaria, Elisa Genuardi, Simone Ragaini, Rita Tavarozzi, Federica Cavallo, Stefan Hohaus, Gerardo Musuraca, Angelo Michele Carella, Caterina Stelitano, Monica Tani, Gianluca Gaidano, Jacopo Olivieri, Sara Veronica Usai, Sara Galimberti, Francesca Re, Michael Mian, Claudia Castellino, Vincenzo Pavone, Andrea Evangelista, Benedetto Bruno, Sergio Cortelazzo, Roberto Passera, Marco Ladetto
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract In the frontline high-dose phase 3 FIL-MCL0208 trial (NCT02354313), 8% of enrolled mantle cell lymphoma (MCL) patients could not be randomised to receive lenalidomide (LEN) maintenance vs observation after autologous stem cell transplantatio
Externí odkaz:
https://doaj.org/article/0fb90bbb8fcd4300b5901399a273825b
Publikováno v:
Biomedical Papers, Vol 168, Iss 2, Pp 139-146 (2024)
Aims. Mucosal Associated Invariant T (MAIT) cells are unconventional T cells with anti-infective potential. MAIT cells detect and fight against microbes on mucosal surfaces and in peripheral tissues. Previous works suggested that MAIT cells survive e
Externí odkaz:
https://doaj.org/article/c4c2b35bae2342eca019abe9468dd0d2
Autor:
Chang Su, Lijun Huang, Liang Liang, Lijia Ou, Guige Lu, Caiqin Wang, Yizi He, Ruolan Zeng, Yajun Li, Hui Zhou, Ling Xiao
Publikováno v:
Infectious Agents and Cancer, Vol 19, Iss 1, Pp 1-5 (2024)
Abstract This paper introduces two cases of multiple myeloma, COVID-19 infection during autologous stem cell transplantation, the treatment process, and different results of the two patients, which provides a reference for how to carry out ASCT safel
Externí odkaz:
https://doaj.org/article/cdf35a87ca4143a89c3cefe3a20088d4
Autor:
Paola Stefanoni, Monica Galli, Laura Paris, Alessandro Rambaldi, Nicola Pittalis, Gianluca Cavallaro, Chiara Pavoni
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
We performed a monocentric, retrospective real-world analysis (RWA) to evaluate the feasibility and the main results of an autologous stem cell transplantation (ASCT)-based program in a cohort of 90 newly diagnosed multiple myeloma patients aged > 65
Externí odkaz:
https://doaj.org/article/388f1920e3554d6c8e62cb8e255dc256
Autor:
Tamara K. Moyo, Rakhee Vaidya
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Historically, salvage chemoimmunotherapy with consolidative autologous hematopoietic stem cell transplantation (ASCT) was the only potentially curative therapeutic option for patients with relapsed/refractory large B-cell lymphoma (LBCL). Treatment o
Externí odkaz:
https://doaj.org/article/2376ea78838d43c7b52a2cec53a03c69
Publikováno v:
Journal of Medical Science (2024)
MM is non-curable cancer that arises from plasma cells and is the second most common type of blood cancer. Drug-refractory relapses are inevitable, making it essential to sustain long-lasting remissions as part of therapy. Lenalidomide maintenance un
Externí odkaz:
https://doaj.org/article/927bb0adac1f474e8ea6b5ee81da1174
Autor:
Martina Canichella, Paolo de Fabritiis
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1721 (2024)
Allogeneic stem cell transplant (ASCT) remains the only treatment option for patients with high-risk acute myeloid leukemia (AML). Recurrence of leukemic cells after ASCT represents a dramatic event associated with a dismal outcome, with a 2-year sur
Externí odkaz:
https://doaj.org/article/f758eb2ec554407aabd528d6ea93feac
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundAngioimmunoblastic T-cell lymphoma (AITL) is characterized by high recurrence rates and poor prognosis, and effective first-line treatment is lacking. Recently, histone deacetylase inhibitors (HDACi), such as chidamide, have been found to i
Externí odkaz:
https://doaj.org/article/5a7518d25ad54e489a0fed264b9f9ef5
Autor:
Andrea M. Cappellano, Natalia Dassi, Bruna M. Mançano, Sidnei Epelman, Daniela B. Almeida, Sergio Cavalheiro, Patricia A. Dastoli, Maria T. S. Alves, Jardel M. Nicacio, Marcos D. S. Costa, Frederico A. Silva, Simone S. Aguiar, Maria L. Figueiredo, Michael Chen, Nasjla S. Silva, Jonathan L. Finlay
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundNon-germinomatous germ cell tumors (NGGCT) accounts for one third of intracranial GCT. While the germinoma group have an excellent overall survival, the standard of practice for children with NGGCT is still under evaluation.AimsDescribe the
Externí odkaz:
https://doaj.org/article/3323d3b79fc54705bea05e4f45b07baf